A phase I randomized controlled trial to evaluate safety and clinical effect of topically applied GSK2981278 ointment in a psoriasis plaque test

被引：32
|
作者：
Kang, E. G. [1 ]
Wu, S. [1 ]
Gupta, A. [1 ]
von Mackensen, Y. -L. [2 ]
Siemetzki, H. [2 ]
Freudenberg, J. M. [1 ]
Wigger-Alberti, W. [2 ]
Yamaguchi, Y. [1 ]
机构：
[1] GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426 USA
[2] Bioskin GmbH, Burchardstr 17, D-20095 Hamburg, Germany
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2018年 / 178卷 / 06期
关键词：
HELPER; 17; CELLS; ROR-GAMMA-T; ORPHAN RECEPTOR;
D O I：
10.1111/bjd.16131
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1427 / 1429
页数：3
相关论文
共 50 条
  • [1] A phase 2a randomized controlled study to evaluate the pharmacokinetic, safety, tolerability and clinical effect of topically applied Umeclidinium in subjects with primary axillary hyperhidrosis
    Nasir, A.
    Bissonnette, R.
    Maari, C.
    DuBois, J.
    Dumitrescu, T. Pene
    Haddad, J.
    Yamaguchi, Y.
    Dalessandro, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (01) : 145 - 151
  • [2] Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial
    Papp, KA
    Bressinck, R
    Fretzin, S
    Goffe, B
    Kempers, S
    Gordon, KB
    Caro, I
    Walicke, PA
    Wang, XL
    Menter, A
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2006, 45 (05) : 605 - 614
  • [3] Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial
    Papp, Kim A.
    Bissonnette, Robert
    Gooderham, Melinda
    Feldman, Steven R.
    Iversen, Lars
    Soung, Jennifer
    Draelos, Zoe
    Mamolo, Carla
    Purohit, Vivek
    Wang, Cunshan
    Ports, William C.
    BMC DERMATOLOGY, 2016, 16
  • [4] A RANDOMIZED CLINICAL TRIAL TO EVALUATE THE SAFETY AND THE EFFECT OF A PROBIOTIC MIXTURE ON PASI INDEX IN PATIENTS WITH MODERATE PSORIASIS
    Navarro-Lopez, V.
    Ruzafa-Costas, B.
    Chenoll-Cuadros, E.
    Ramon-Vidal, D.
    Genoves-Martinez, S.
    Paya-Espinosa, Y.
    Codoner-Cortes, F.
    Carrion-Gutierrez, M.
    ANNALS OF NUTRITION AND METABOLISM, 2018, 72 : 40 - 41
  • [5] A Phase I Clinical Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Immunogenicity of Ebdarokimab in Patients with Moderate to Severe Plaque Psoriasis
    Chen, Rui
    Xia, Yu
    Li, Baiyong
    Ni, Xiang
    Wang, Guoqin
    Zhang, Cui
    Chen, Benchao
    Wang, Li
    Jin, Hongzhong
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1495 - 1497
  • [6] Neovastat (Æ-941), an inhibitor of angiogenesis:: Randomized phase I/II clinical trial results in patients with plaque psoriasis
    Sauder, DN
    DeKoven, J
    Champagne, P
    Croteau, D
    Dupont, E
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (04) : 535 - 541
  • [7] A phase 2a study to evaluate the safety, tolerability, and clinical effect of topically applied umeclidinium in subjects with primary axillary hyperhidrosis
    Nasir, Adnan
    Bissonnette, Robert
    DuBois, Janet
    Maari, Catherine
    Haddad, Jonathan
    Yamaguchi, Yuji
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB20 - AB20
  • [8] Efficacy and safety of piclidenoson in plaque psoriasis: Results from a randomized phase 3 clinical trial (COMFORT-1)
    Papp, K. A.
    Beyska-Rizova, S.
    Gantcheva, M. L.
    Slavcheva Simeonova, E.
    Brezoev, P.
    Celic, M.
    Groppa, L.
    Blicharski, T.
    Selmanagic, A.
    Kalicka-Dudzik, M.
    Calin, C. A.
    Trailovic, N.
    Ramon, M.
    Bareket-Samish, A.
    Harpaz, Z.
    Farbstein, M.
    Silverman, M. H.
    Fishman, P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (06) : 1112 - 1120
  • [9] A phase I randomized trial to assess the effect on skin infiltrate thickness and tolerability of topical phosphodiesterase inhibitors in the treatment of psoriasis vulgaris using a modified psoriasis plaque test
    Snape, S. D.
    Wigger-Alberti, W.
    Goehring, U. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (03) : 479 - 486
  • [10] A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction
    Papp, KA
    Tyring, S
    Lahfa, M
    Prinz, J
    Griffiths, CEM
    Nakanishi, AM
    Zitnik, R
    van de Kerkhof, PCM
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (06) : 1304 - 1312
12345